MedX Holdings – MEDX OTC This company has recently raised $5.2 Million through sales of its real estate holdings and is moving forward on the purchase of 163 acres where high quality, high purity, Pharma Grade water is located. Pharma Grade water is used for irrigation of wounds , surgery , injection and other medical uses .
This water could be worth as much as $60 gal.
This project could propel this company to much higher levels . we urge serious investors to immediately place these shares on their BUY LIST
AUSTIN, Texas, Oct. 22, 2019 (GLOBE NEWSWIRE) — SmallCapVoice.com (SCV) and MedX Holdings, Inc. (OTC Pink: MEDH) (the Company), today announced that Company CEO, Mark Miller, is featured in a new audio interview at SmallCapVoice.com.
Mark Miller called in to SmallCapVoice.com to provide the MEDH shareholders and the SCV listening audience with details of the recent sale of residential real estate assets, the use of funds from that transaction, details regarding the acquisition of BioHydro LLC, the new direction for the Company stemming from that acquisition, and the operational goals for the remainder of 2019. PHARMA GRADE WATER
“With the sale of our residential real estate that generated in excess of $5.5 million dollars in net profits, the Company is now funded for future growth. This move allows us to suspend our current fundraising efforts thereby eliminating the threat of dilution to our current shareholders. As stated previously, management believes that the BioHydro opportunity presents a viable avenue for exponential revenue generation,” stated Miller. “That makes this a great time to go on the record with the knowledgeable listeners at SmallCapVoice.com. We have an extremely compelling story to tell right now given the tremendous progress we have already made and the important steps that lie in front of us as we break into an enormous market opportunity in our new market.”
COMPANY EXPANDS INTO NEW INDUSTRY SECTOR
MedX Holdings, Inc. (OTC Pink: MEDH) (the Company) is pleased to announce the acquisition of BioHydro LLC.
BioHydro is the servicing arm that will manage the development, infrastructure, and construction of a processing facility in Arizona’s saturated zone, for the purpose of targeting approximately 2 trillion gallons of pharmaceutical grade water on 163 acre parcels. This particular grade of water has already been tested for characteristics; such as, purity and high Ph factors, which makes it a highly desirable commodity for pharmaceutical and biological applications. Industry leaders retail their PHarma H2O in excess of $60.00 per gallon, and we are currently evaluating a per gallon price for our entry into this market.
MedX Holdings and BioHydro will be managed by an expert with over 30 years in complex real estate transactions. These interior corporate changes will be transitioned seamlessly over the next few weeks and we encourage shareholders to follow our Twitter account for updates.
The BioHydro opportunity presents a viable avenue for exponential revenue generation; which has the company re-evaluating its current residential real estate and construction subsidiaries for possible unwinding to fully focus on its entry as a service provider to the pharmaceutical industry.
Stated CEO, Mark Miller: “In the coming weeks the company will be doing a series of audio interviews that will explain in greater detail the new industry sector and the opportunity for significant revenue generation. We will also be discussing the corporate changes, and why the company felt it was important to make this move.”
Follow us on Twitter @MedX_Holdings
Safe-Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company’s financing plans; (ii) trends affecting the company’s financial condition or results of operations; (iii) the company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements.
Neither PSN nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PSN website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PSN website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PSN website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision.